Aspen Aerogels (NYSE:ASPN) Issues FY 2024 Earnings Guidance

Aspen Aerogels (NYSE:ASPNGet Free Report) issued an update on its FY 2024 earnings guidance on Wednesday morning. The company provided EPS guidance of 0.110-0.110 for the period, compared to the consensus EPS estimate of 0.15. The company issued revenue guidance of $450.0 million-$450.0 million, compared to the consensus revenue estimate of $415.8 million. Aspen Aerogels also updated its FY24 guidance to $0.11 EPS.

Analysts Set New Price Targets

Several equities analysts have weighed in on the stock. Benchmark restated a “buy” rating and set a $14.00 target price on shares of Aspen Aerogels in a report on Thursday, August 8th. HC Wainwright restated a “buy” rating and set a $30.00 price objective on shares of Aspen Aerogels in a research report on Wednesday, October 16th. Roth Mkm lowered their target price on Aspen Aerogels from $36.00 to $31.00 and set a “buy” rating on the stock in a report on Friday. TD Cowen boosted their price target on Aspen Aerogels from $36.00 to $41.00 and gave the stock a “buy” rating in a report on Tuesday, August 20th. Finally, StockNews.com raised Aspen Aerogels to a “sell” rating in a research note on Thursday, October 31st. One research analyst has rated the stock with a sell rating, nine have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, Aspen Aerogels currently has a consensus rating of “Moderate Buy” and a consensus price target of $28.90.

View Our Latest Analysis on ASPN

Aspen Aerogels Stock Down 1.7 %

Shares of ASPN stock traded down $0.28 during trading hours on Friday, reaching $16.49. The company had a trading volume of 4,214,385 shares, compared to its average volume of 3,088,569. The stock’s fifty day simple moving average is $23.10 and its 200 day simple moving average is $24.61. The company has a market capitalization of $1.27 billion, a P/E ratio of 1,650.65 and a beta of 2.21. The company has a debt-to-equity ratio of 0.23, a quick ratio of 2.82 and a current ratio of 3.46. Aspen Aerogels has a twelve month low of $8.76 and a twelve month high of $33.15.

Aspen Aerogels (NYSE:ASPNGet Free Report) last issued its quarterly earnings data on Wednesday, August 7th. The construction company reported $0.21 EPS for the quarter, topping analysts’ consensus estimates of $0.05 by $0.16. Aspen Aerogels had a net margin of 0.36% and a return on equity of 5.08%. The firm had revenue of $117.80 million for the quarter, compared to analyst estimates of $101.99 million. During the same quarter in the previous year, the business posted ($0.22) EPS. The firm’s revenue was up 144.4% compared to the same quarter last year. As a group, sell-side analysts expect that Aspen Aerogels will post 0.1 earnings per share for the current fiscal year.

Insider Buying and Selling at Aspen Aerogels

In related news, CFO Ricardo C. Rodriguez sold 32,465 shares of the business’s stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $30.14, for a total value of $978,495.10. Following the completion of the sale, the chief financial officer now directly owns 20,790 shares of the company’s stock, valued at $626,610.60. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In related news, CEO Donald R. Young sold 63,355 shares of the stock in a transaction dated Monday, September 30th. The shares were sold at an average price of $30.03, for a total transaction of $1,902,550.65. Following the sale, the chief executive officer now owns 483,640 shares in the company, valued at $14,523,709.20. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Ricardo C. Rodriguez sold 32,465 shares of Aspen Aerogels stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $30.14, for a total value of $978,495.10. Following the completion of the transaction, the chief financial officer now owns 20,790 shares of the company’s stock, valued at approximately $626,610.60. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 4.30% of the stock is currently owned by insiders.

About Aspen Aerogels

(Get Free Report)

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.

Further Reading

Earnings History and Estimates for Aspen Aerogels (NYSE:ASPN)

Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.